BYETTA is a non-insulin type 2 diabetes injection medication for adults. Learn about BYETTA, the BYETTA Pen. in patients with prior severe hypersensitivity reactions to exenatide or to any of the product components. Patient Information Leaflet. Package leaflet: Information for the patient. Byetta 5 micrograms solution for injection in pre-filled pen. Byetta 10 micrograms solution .
|Published (Last):||11 January 2005|
|PDF File Size:||14.46 Mb|
|ePub File Size:||12.93 Mb|
|Price:||Free* [*Free Regsitration Required]|
Use in pediatric patients is not recommended as safety and effectiveness have not been established. AstraZeneca provides this link as a service to website visitors.
The most common side effects nisert BYETTA include nausea, vomiting, diarrhea, feeling jittery, dizziness, headache, acid stomach, constipation, and weakness.
Oral medications dependent on threshold concentrations for efficacy, such as contraceptives or antibiotics, should be taken at least 1 hour before BYETTA. Should not be used in patients with severe renal impairment or end-stage renal disease. BYETTA has been associated with acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis, based on postmarketing data.
Isert slows gastric emptying and can reduce the extent and rate of absorption of orally administered drugs. Write your html here Tell your healthcare provider if you are pregnant or plan to become pregnant. Not a substitute for insulin and should not be used in patients with type 1 diabetes or diabetic ketoacidosis. Because exenatide is commonly associated with gastrointestinal adverse reactions, BYETTA is not recommended in patients with severe gastrointestinal disease eg gastroparesis.
Based on animal data, BYETTA may cause fetal harm and should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is unknown whether patients with a history of pancreatitis are at increased risk for pancreatitis while using BYETTA; consider other antidiabetic therapies for these patients.
Official BYETTA® (exenatide) injection Healthcare Professional Website
Stop taking BYETTA and call your healthcare provider right away if you have pain in your stomach area abdomen that is severe, and will not go away, occurs with or without vomiting or is felt going from your abdomen through to your back. Call your bgetta provider right away if you have nausea, vomiting, or diarrhea that will not go away, or if you cannot take liquids by mouth.
Add BYETTA to insulin glargine as a complementary action to help improve glycemic control
Patients may develop antibodies to exenatide. The most frequently reported adverse reactions leading to withdrawal for Byetta-treated patients were nausea 5. Paclage to Patient Site. If pancreatitis is suspected, BYETTA should be discontinued promptly and should not be restarted if pancreatitis is confirmed.
Increased risk of hypoglycemia when used in combination with a sulfonylurea SU or when used with a glucose-independent insulin secretagogues eg, meglitinides.
BYETTA is indicated beytta an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Use with caution with medications that have a narrow therapeutic index or require rapid gastrointestinal absorption. Glucagon-like peptide-1 receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetes.
This site is intended for Packabe Consumers. Inflammation of the pancreas pancreatitis may happen, which may be severe and lead to death. Your risk for getting low blood sugar hypoglycemia is higher if you take BYETTA with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. No placebo-treated patients withdrew due to nausea or vomiting. Use with caution in patients with renal transplantation or when initiating or escalating the dose in patients with moderate renal failure.
Pafkage used with insulin, evaluate and consider reducing the insulin dose in patients at increased risk of hypoglycemia. The Double B logo is a trademark of the AstraZeneca group of companies. All other trademarks are property of their respective owners. Padkage reports of altered renal function, including increased serum creatinine, renal impairment, worsened chronic renal pckage, and acute renal failure, sometimes requiring hemodialysis and kidney transplantation.
Approved Uses BYETTA is an injectable prescription medicine that may improve blood sugar glucose control in adults with type 2 diabetes, when used with diet and exercise.
To report drug exposure during pregnancy call This product information is intended for US Healthcare Professionals only.
Postmarketing reports of serious hypersensitivity reactions eg anaphylaxis and angioedema. BYETTA is an injectable prescription medicine that may improve blood sugar glucose control in adults with type 2 diabetes, when used with diet and exercise.
Go to Healthcare Professional Site. You are encouraged to report negative side effects of prescription drugs to the FDA. Symptoms of a severe allergic reaction include severe rash or itching, swelling of your face, lips, and throat that may cause difficulty breathing or swallowing, feeling faint or dizzy and very rapid heartbeat. Signs and symptoms of low blood sugar may include headache, drowsiness, weakness, dizziness, confusion, irritability, hunger, fast heartbeat, sweating, and feeling jittery.
The site you are about to visit is maintained by a third party who is solely responsible for its contents. These may be symptoms of pancreatitis. After initiation and dose increases of BYETTA, observe patients carefully for pancreatitis including persistent severe abdominal pain, sometimes radiating to the back, with or without vomiting. Drug Interactions Oral Medications: Use of twice-daily exenatide in basal insulin—treated patients with type 2 diabetes: Staying Active Learn how regular physical activity can help you manage type 2 diabetes.
Postmarketing reports of increased international normalized ratio INR sometimes associated with bleeding with concomitant use of warfarin. If worsening of or failure to achieve adequate glycemic control occurs, consider alternative antidiabetic therapy.